As card brands pressure processors to decline or cancel peptide merchant accounts, 2nd Amendment Processing continues helping eligible businesses explore ACH and cryptocurrency payment options.

Across the peptide, compounding, telehealth, wellness, and research industries, businesses are reporting a troubling pattern: terminated merchant accounts, frozen funds, rejected applications, excessive reserves, and sudden restrictions tied to peptide-related products. These actions can financially cripple a lawful business—sometimes without a meaningful explanation, individualized review, or opportunity to appeal. The time has come to determine whether these were independen

Eli Lilly’s tirzepatide patent should not become a blanket ban on peptide processing. We examine Visa’s penalties, corporate pressure, and the growing threat of financial deplatforming.

2nd Amendment Processing has partnered with accept.blue to expand our payment gateway, e-commerce, CRM, ERP, ACH, invoicing and point-of-sale integration capabilities.

Have stablecoins replaced XRP? Not quite. While stablecoins are transforming digital payments with price stability and faster settlements, XRP continues to play a unique role in cross-border liquidity and currency exchange. Learn the differences, why both technologies matter, and what their growing adoption means for businesses looking to stay ahead in the future of payment processing.